<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eight patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) and two patients with <z:hpo ids='HP_0004810'>congenital hypoplastic anemia</z:hpo> (CHA) were treated with absorbed samples of rabbit anti-thymocyte globulin (ATG) at a total dose of 50-75 mg/kg body weight intravenously over 5 days </plain></SENT>
<SENT sid="1" pm="."><plain>Duration of the disease was 1-14 years </plain></SENT>
<SENT sid="2" pm="."><plain>Median age of the ten patients was 11 (4-15) years </plain></SENT>
<SENT sid="3" pm="."><plain>Four of the eight patients with SAA were responders and transfusion independent for a follow up of 11 to 50 months </plain></SENT>
<SENT sid="4" pm="."><plain>In two cases <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> of about 100 000/mm3 is present </plain></SENT>
<SENT sid="5" pm="."><plain>Four patients were non-responders three of them died in the meantime by the underlining disease </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients with CHA did not respond to ATG treatment </plain></SENT>
<SENT sid="7" pm="."><plain>The CFU-C level of <z:hpo ids='HP_0000001'>all</z:hpo> eight patients with SAA before treatment was severely decreased </plain></SENT>
<SENT sid="8" pm="."><plain>In co-culture studies with <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow no growth inhibition of <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow could be demonstrated </plain></SENT>
<SENT sid="9" pm="."><plain>Also 20% patients serum did not inhibit <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow growth </plain></SENT>
<SENT sid="10" pm="."><plain>The results are compared with data from literature and discussed in respect to alternative therapies </plain></SENT>
</text></document>